Exelon (EXC)
NASDAQUtilitiesUtilities - Regulated ElectricSnapshot 2026-07-07
$47.57+1.11%
Close 2026-07-07 · 1-day change
Reading EXC? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track EXC free→NASDAQUtilitiesUtilities - Regulated ElectricSnapshot 2026-07-07
Reading EXC? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track EXC free→QuarterlyIQ Insights · EXC
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 11 valuation methods, at three horizons. Current price $47.57. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $48 EXC trades at 1.7× p/b, below its 2.3× p/b peer median, but our blended $48 fair value is roughly in line with the price. It's a high-confidence read. Analysts target $41–$55. Not investment advice.
$41.00 – $55.00 (median $49.00) · 10 analysts · as of 2026-05-29
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $49.00 | — | — | Analyst | high |
| ddm gordon | 12M | $28.38 | — | — | TTM | high |
| graham number | 12M | $42.05 | — | — | TTM | high |
| Mgmt guidance | 12M | $69.89 | 24.4 | 2.86 | Mgmt | high |
| Peer P/B | 12M | $66.50 | 2.3 | 28.57 | TTM | high |
| Peer P/E | 12M | $67.20 | 24.4 | 2.75 | TTM | high |
| Peer P/S | 12M | $74.22 | 3.1 | 24.16 | TTM | high |
| PEG | 12M | $63.61 | 23.1 | 2.75 | TTM | high |
| residual income | 12M | $29.99 | — | — | TTM | high |
| Own P/E history | 12M | $45.04 | 16.4 | 2.75 | TTM | high |
| triangulated | 12M | $68.48 | 24.4 | 2.80 | Triangulated | high |
| Mgmt guidance | 3Y | $85.49 | 24.4 | 3.50 | Mgmt(prov.) | medium |
| Peer P/B | 3Y | $77.77 | 2.3 | 33.42 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $78.71 | 24.4 | 3.22 | Analyst | medium |
| Peer P/S | 3Y | $83.11 | 3.1 | 27.05 | Analyst | medium |
| PEG | 3Y | $74.50 | 23.1 | 3.22 | Analyst | medium |
| Own P/E history | 3Y | $52.75 | 16.4 | 3.22 | Analyst | medium |
| Mgmt guidance | 5Y | $97.79 | 24.4 | 4.00 | Mgmt(prov.) | high |
| Peer P/B | 5Y | $86.33 | 2.3 | 37.09 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $84.74 | 24.4 | 3.47 | Analyst | high |
| Peer P/S | 5Y | $89.48 | 3.1 | 29.13 | Analyst | high |
| PEG | 5Y | $80.21 | 23.1 | 3.47 | Analyst | high |
| Own P/E history | 5Y | $56.79 | 16.4 | 3.47 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.